Actuate Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Actuate Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Actuate Therapeutics, Inc (NASDAQ:ACTU) IPO will take place July, 24 on the NASDAQ exchange under the ticker ACTU.
Actuate Therapeutics, Inc（納斯達克股票代碼：ACTU）的首次公開募股將於7月24日在納斯達克交易所進行，股票代碼爲ACTU。
The company is offering shares at an expected price between $8.00 and $10.00 per share with an insider lock-up period of 180 days ending on January 20, 2025.
該公司發行股票的預期價格在每股8.00美元至10.00美元之間，內部封鎖期爲180天，將於2025年1月20日結束。
See also: Benzinga IPO Calendar
另見：Benzinga IPO 日曆
About Actuate Therapeutics, Inc
Actuate 治療公司簡介
Actuate Therapeutics, Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3
Actuate Therapeutics, Inc是一家臨床階段的生物製藥公司，專注於開發通過抑制糖原合酶激酶-3來治療影響大、難以治療的癌症的療法
See also: Benzinga's Most Shorted Stocks
另見：本辛加最常做空的股票
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。